Table 1.

Phenotypes reported in Syndecan-1 Null Mice

Reduced breast cancer tumor development	Alexander, et al., 2000 [8]
	McDermott, et al., 2007 [9]
Increased inflammation	Gotte, et al., 2002 [10]
	Gotte, et al., 2005 [6]
Delayed corneal and skin wound healing	Stepp, et al., 2002 [7]
Reduced bacterial pathogenesis	Park, et al., 2004 [11]
	Haynes, et al., 2005 [12]
Increased complications after coronary myocardial infarction	Vanhoutte, et al., 2007 [13]
Increased severity of anti-GBM nephritis	Rops, et al., 2007 [14]
Reduced migration and increased integrin function in keratinocytes	Stepp, et al., 2007 [15]